Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > Articles by: Marie Berger
10 Years !
2023 January Jan 09

10 Years !

Read more
PRAC recommendations-signals adopted
2023 January Jan 06

PRAC recommendations-signals adopted

Read more
2023 January Jan 03

Read more
Italy : AIFA OPERATING PROCEDURE for local pharmacovigilance managers : Management of reports in the national pharmacovigilance network
2023 January Jan 02

Italy : AIFA OPERATING PROCEDURE for local pharmacovigilance managers : Management of reports in the national pharmacovigilance network

Read more
Monitoring of adverse drug reactions in the management of Covid-19 as of 8-Dec-2022
2022 December Dec 30

Monitoring of adverse drug reactions in the management of Covid-19 as of 8-Dec-2022

https://ansm.sante.fr/actualites/suivi-des-effets-indesirables-des-medicaments-utilises-dans-la-prise-en-charge-du-covid-19-en-date-du-8-12-2022

Read more
Denmark : Guideline Application for Individual or General Compassionate Use Permit, 16-Dec-2022
2022 December Dec 26

Denmark : Guideline Application for Individual or General Compassionate Use Permit, 16-Dec-2022

Read more
2022 December Dec 23

Read more
EU: Marketing Authorization Holders involved in GMP, GCP and GVP inspections coordinated by EMA
2022 December Dec 19

EU: Marketing Authorization Holders involved in GMP, GCP and GVP inspections coordinated by EMA

Read more
EU: meeting highlights from the CHMP
2022 December Dec 16

EU: meeting highlights from the CHMP

Read more
Australia: Pharmacovigilance Inspection Program
2022 December Dec 05

Australia: Pharmacovigilance Inspection Program

Read more
  • « Previous

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • The European Medicines Agency (EMA) is delivering a Product Management Service (PMS) and a Substance Management Service (SMS) to support regulatory activities in the European Union (EU)
  • Drug clinical trials: the CTIS portal becomes the sole entry point for new requests as of the 31st of January 2023
  • Work Plan 2023 of the Pharmacovigilance Risk Assessment Committee (PRAC)
Copyright © 2018 - Pharmya - Legal terms - Quality Policy